Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core

Journal of Neuroscience

Volumn 23, Issue 15, 2003, Pages 6295-6303

  Sellings, Laurie H L ^a   Clarke, Paul B S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

6 hydroxydopamine; Amphetamine; Conditioned place preference; Locomotion; Morphine; Nucleus accumbens core; Nucleus accumbens medial shell; Reward

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; AMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; IODINE 125; MORPHINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN INJURY; CONDITIONED REFLEX; CONTROLLED STUDY; DOPAMINE RELEASE; GENE EXPRESSION; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NEUROPATHOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; NUCLEUS ACCUMBENS CORE; NUCLEUS ACCUMBENS MEDIAL SHELL; PHARMACOLOGICAL STIMULATION; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REWARD; SENSORY DYSFUNCTION; TOUCH;

EID: 0038043869     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-15-06295.2003     Document Type: Article

References (75)

1. Acquas E, Di Chiara G (1994) D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion. Behav Pharmacol 5:555-569.
2. Archer T, Fredriksson A, Jonsson G, Lewander T, Mohammed AK, Ross SB, Soderberg U (1986) Central noradrenaline depletion antagonizes aspects of D-amphetamine-induced hyperactivity in the rat. Psychopharmacology 88:141-146.
3. Auclair A, Cotecchia S, Glowinski J, Tassin J-P (2002) D-Amphetamine fails to increase extracellular dopamine levels in mice lacking α1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. J Neurosci 22:9150-9154.
4. Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31-43.
5. Bardo MT, Valone JM, Bevins RA (1999) Locomotion and conditioned place preference produced by acute intravenous amphetamine: role of dopamine receptors and individual differences in amphetamine self-administration. Psychopharmacology 143:39-46.
6. Bechara A, van der Kooy D (1992) A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not in deprived rats. Behav Neurosci 106:351-363.
7. Bechara A, Harrington F, Nader K, van der Kooy D (1992) Neurobiology of motivation: double-dissociation of two motivational mechanisms mediating opiate reward in drug-naive vs. drug-dependent animals. Behav Neurosci 106:798-807.
8. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning or incentive salience? Brain Res Rev 28:309-369.
9. Blanc G, Trovero F, Vezina P, Herve D, Godeheu A-M, Glowinski J, Tassin J-P (1994) Blockade of prefronto-cortical alpha1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci 6:293-298.
10. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12:27-36.
11. Boye SM, Grant RJ, Clarke PBS (2001) Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats. Neuropharmacology 40:792-805.
12. Burns LH, Robbins TW, Everitt BJ (1993) Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine. Behav Brain Res 55:167-183.
13. Campbell A, Villavicencio AT, Yeghiayan SK, Balikian R, Baldessarini RJ (1997) Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain. Brain Res 771:55-62.
14. Carlezon WA, Wise RA (1996) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16:3112-3122.
15. Carr GD, White NM (1991) Conditioned place preference from intraaccumbens but not intra-caudate amphetamine injections. Life Sci 33:2551-2557.
16. Chevrette J, Stellar JR, Hesse GW, Markou A (2001) Both the shell of the nucleus accumbens and the central nucleus of the amygdala support amphetamine self-administration in rats. Pharmacol Biochem Behav 71:501-507.
17. Clarke PBS, Jakubovic A, Fibiger HC (1988) Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of D-amphetamine and apomorphine. Psychopharmacology 96:511-520.
18. Clarke PBS, White NM, Franklin KB (1990) 6-Hydroxydopamine lesions of the olfactory tubercle do not alter (+)-amphetamine-conditioned place preference. Behav Brain Res 36:185-188.
19. Cools AR (1986) Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens. Psychopharmacology 88:451-459.
20. 125I]RTI-55. Brain Res 690:217-224.
21. Darracq L, Blanc G, Glowinski J, Tassin JP (1998) Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18:2729-2739.
22. Di Chiara G (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38:95-137.
23. Dickinson SL, Gadie B, Tulloch IF (1988) Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by D-amphetamine and apomorphine in the rat. Psychopharmacology 96:521-527.
24. Dickson PR, Lang CG, Hinton SC, Kelley AE (1994) Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 61:81-91.
25. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, Tassin JP (2002a) Alpha1-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22:2873-2884.
26. Drouin C, Blanc G, Villegier AS, Glowinski J, Tassin JP (2002b) Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics. Synapse 43:51-61.
27. Essman WD, McGonigle P, Lucki I (1993) Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and D-amphetamine. Psychopharmacology 112:233-241.
28. Fink JS, Smith GP (1979) Abnormal pattern of amphetamine locomotion after 6-OHDA lesion of anteromedial caudate. Pharmacol Biochem Behav 11:23-30.
29. Fink JS, Smith GP (1980) Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats. Brain Res 199:359-384.
30. Harro J, Merikula A, Lepiku M, Modiri AR, Rinken A, Oreland L (2000) Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats. Pharmacol Toxicol 86:197-202.
31. Heidbreder C, Feldon J (1998) Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 29:310-322.
32. Hiroi N, White NM (1990) The reserpine-sensitive dopamine pool mediates(+)-amphetamine-conditioned reward in the place preference paradigm. Brain Res 510:33-42.
33. Hiroi N, White NM (1991a) The lateral nucleus of the amygdala mediates expression of the amphetamine-produced conditioned place preference. J Neurosci 11:2107-2116.
34. Hiroi N, White NM (1991b) The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res 552:141-152.
35. Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L (1983) Self-injection of amphetamine directly into the brain. Psychopharmacology 81:158-163.
36. Ikemoto S (2002) Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113:939-955.
37. Ikemoto S, Glazier BS, Murphy JM, McBride WJ (1997) Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci 17:8580-8587.
38. Izzo E, Orsini C, Koob GF, Pulvirenti L (2001) A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule. Pharmacol Biochem Behav 68:701-708.
39. Joyce EM, Stinus L, Iversen SD (1983) Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity. Neuropharmacology 22:1141-1145.
40. Joyce JN (1991a) Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system. Exp Neurol 113:261-276.
41. Joyce JN (1991b) Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment. Exp Neurol 113:277-290.
42. Kelley AE, Smith-Roe SL, Holahan MR (1997) Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Proc Natl Acad Sci USA 94:12174-12179.
43. Kelly PH, Iversen SD (1976) Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56.
44. Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507-522.
45. Koob GF, Sanna PP, Bloom FE (1998) Neuroscience of addiction. Neuron 21:467-476.
46. Laviolette SR, Nader K, van der Kooy D (2002) Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes. Behav Brain Res 129:17-29.
47. Lyness WH, Friedle NM, Moore KE (1979) Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on D-amphetamine self-administration. Pharmacol Biochem Behav 11:553-556.
48. Mackey WB, van der Kooy D (1985) Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning. Pharmacol Biochem Behav 22:101-105.
49. Maldonado-Irizarry CS, Kelley AE (1995) Excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat. Brain Res Bull 38:551-559.
50. Nader K, van der Kooy D (1997) Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area. J Neurosci 17:383-390.
51. Ogren SO, Archer T, Johansson C (1983) Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat. Neurosci Lett 43:327-331.
52. Parkinson JA, Olmstead MC, Burns LH, Robbins TW, Everitt BJ (1999) Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive Pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J Neurosci 19:2401-2411.
53. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, Ed 3. San Diego: Academic.
54. Phillips GD, Robbins TW, Everitt BJ (1994) Bilateral intra-accumbens self-administration of D-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride. Psychopharmacology 114:477-485.
55. Pierce RC, Kalivas PW (1995) Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J Pharmacol Exp Ther 275:1019-1029.
56. Pijnenburg AJ, Honig WM, Van Rossum JM (1975) Inhibition of D-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacologia 41:87-95.
57. Pijnenburg AJ, Honig WM, van der Heyden JA, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45-58.
58. 125I]epibatidine-labeled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents. Brain Res 954:227-236.
59. Redgrave P, Prescott TJ, Gurney K (1999) Is the short-latency dopamine response too short to signal reward error? Trends Neurosci 22:146-151.
60. Robbins TW, Roberts DC, Koob GF (1983) Effects of D-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. J Pharmacol Exp Ther 224:662-673.
61. Roberts DCS, Zis AP, Fibiger HC (1975) Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine. Brain Res 93:441-454.
62. Roberts DCS, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6:615-620.
63. Robledo P, Maldonado R, Koob GF (1993) Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res 622:105-112.
64. Schultz W (2002) Getting formal with dopamine and reward. Neuron 36:241-263.
65. Shippenberg TS, Bals-Kubik R, Herz A (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265:53-59.
66. Spyraki C, Fibiger HC, Phillips AG (1982) Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res 253:185-193.
67. Spyraki C, Fibiger HC, Phillips AG (1983) Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278-283.
68. Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S (2003) Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci 23:1879-1885.
69. Vezina P, Stewart J (1987) Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an open field. Psychopharmacology 91:375-380.
70. Weiner I, Gal G, Rawlins JN, Feldon J (1996) Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behav Brain Res 81:123-133.
71. West CH, Boss-Williams KA, Weiss JM (1999) Motor activation by amphetamine infusion into nucleus accumbens core and shell subregions of rats differentially sensitive to dopaminergic drugs. Behav Brain Res 98:155-165.
72. Wise RA (2002) Brain reward circuitry: insights from unsensed incentives, Neuron 36:229-240.
73. Yokel RA, Wise RA (1975) Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187:547-549.
74. Yokel RA, Wise RA (1976) Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48:311-318.
75. Zahm DS, Brog JS (1992) On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience 50:751-767.